ClinVar Miner

Submissions for variant NM_000303.3(PMM2):c.324del (p.Ile110fs) (rs1555449314)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000599337 SCV000709891 pathogenic not provided 2017-11-06 criteria provided, single submitter clinical testing The c.324delG pathogenic variant in the PMM2 gene has been reported previously in association with congenital disorder of glycosylation type 1a (CDG-1a) (Mattijs et al., 1998). The deletion causes a frameshift starting with codon Isoleucine 110, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 18 of the new reading frame, denoted p.Ile110LeufsX18. This variant is not observed in large population cohorts (Lek et al., 2016). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense mediated mRNA decay.
Counsyl RCV000670380 SCV000795225 likely pathogenic Congenital disorder of glycosylation, type Ia 2017-11-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.